Hydrangenol suppresses VEGF-stimulated angiogenesis by targeting p27KIP1-dependent G1-cell cycle arrest, VEGFR-2-mediated signaling, and MMP-2 expression
Autor: | Sung-Kwon Moon, Kisung Ko, Wun-Jae Kim, Yung Hyun Choi, Yujeong Gho, Seung-Shick Shin |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Angiogenesis VEGF receptors Human bladder Matrix metalloproteinase General Biochemistry Genetics and Molecular Biology 03 medical and health sciences chemistry.chemical_compound angiogenesis 0302 clinical medicine Hydrangenol medicine lcsh:QH301-705.5 HUVECs lcsh:R5-920 biology Chemistry Cancer medicine.disease VEGF In vitro 030104 developmental biology lcsh:Biology (General) 030220 oncology & carcinogenesis Cancer research biology.protein Molecular & Cellular Biology Animal Science and Zoology lcsh:Medicine (General) G1 phase ex vivo aortic ring |
Zdroj: | Animal Cells and Systems, Vol 23, Iss 2, Pp 72-81 (2019) Animal Cells and Systems |
ISSN: | 2151-2485 1976-8354 |
Popis: | We previously reported that hydrangenol has potent antitumor activity against human bladder cancer EJ cells. Here, we investigated the antiangiogenic activity of hydrangenol using in vitro and ex vivo models. Treatment with hydrangenol significantly inhibited the proliferation of vascular endothelial growth factor (VEGF)-induced HUVECs in a concentration-dependent manner (EC50 = 10 μM). Flow cytometry analysis revealed that hydrangenol suppressed the VEGF-induced inhibition of G1-cell cycle phase and also decreased cyclin D1, cyclin E, CDK2, and CDK4 levels. Hydrangenol-mediated arrest in the G1-cell cycle phase was associated with p27KIP1 level, but not p21WAF1 or p53 level. Hydrangenol also significantly inhibited VEGFR-2-mediated signaling pathways including ERK1/2, AKT, and endothelial nitric oxide synthase. Interestingly, immunoprecipitation assay demonstrated that the inhibition of VEGFR-2 activation was independent of VEGF binding, thereby suggesting an allosteric regulation of hydrangenol against VEGFR-2. Additionally, hydrangenol inhibited migration, invasion, and capillary-like tubular formation in VEGF-stimulated HUVECs. Zymography and immunoblot analyses revealed that these inhibitory activities were partially owing to the VEGF-induced inhibition of matrix metalloproteinase-2 activity. Finally, VEGF-mediated microvessel sprouting was inhibited in the presence of hydrangenol in ex vivo aortic ring assay. Taken together, hydrangenol possesses a potent antiangiogenesis potential; thus we believe that hydrangenol may be developed as a therapeutic reagent to treat angiogenesis-mediated diseases. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |